Strabismus is a common ocular disorder characterized by horizontal,vertical,and/or torsional misalignment of the visual axes.Accurate assessment of the type and magnitude of ocular deviation is essential for treatment selection and surgical planning.However,conventional diagnosis and surgical decision-making still rely heavily on clinical experience,manual observation,patient cooperation,and local availability of trained specialists.These factors may lead to variability in measurement and limit access to timely screening and referral in primary care settings.In recent years,artificial intelligence,deep learning,eye tracking,virtual reality,and other digital health technologies have provided new opportunities for objective and quantitative assessment of strabismus.This narrative review summarizes representative advances in digital diagnosis and intelligent surgical planning for strabismus,with an emphasis on clinical tasks,data modalities,algorithmic approaches,validation status,and application boundaries.For digital diagnosis,image-and video-based deep learning models have been explored for screening,subtype classification,and estimation of ocular deviation.Wearable or infrared eye-tracking systems can capture dynamic binocular coordination and may be particularly useful for intermittent strabismus or subtle abnormalities that are difficult to identify from a single static image.Smartphone-based and embedded systems may improve accessibility in community screening and remote follow-up,although their roles are currently better defined as risk stratification tools rather than replacements for specialist diagnosis.For surgical planning,machine learning regression,multi-task learning,artificial intelligence platforms based on corneal light-reflection photographs,biomechanical modeling,and virtual reality simulation have been investigated to support muscle selection,dosage prediction,and surgical training.These studies suggest that artificial intelligence may help standardize parts of the diagnostic and planning workflow.Nevertheless,current evidence remains limited by small or single-center datasets,retrospective design,internal validation,heterogeneous reference standards,and underrepresentation of complex strabismus,reoperations,vertical or torsional deviations,and patients with combined ocular or neurological conditions.Therefore,the performance reported in controlled studies should not be directly interpreted as readiness for autonomous clinical decision-making.Future research should prioritize standardized multimodal data acquisition,multicenter external validation,prospective real-world evaluation,explainable models,integration with clinical workflows,long-term outcome prediction,and clear ethical,regulatory,and responsibility frameworks.Artificial intelligence is more likely to become a safe and useful adjunct to strabismus care when it is developed as part of a clinician-centered,interpretable,and verifiable decision-support system.